Cargando…
ERF deletion rescues RAS deficiency in mouse embryonic stem cells
MEK inhibition in combination with a glycogen synthase kinase-3β (GSK3β) inhibitor, referred as the 2i condition, favors pluripotency in embryonic stem cells (ESCs). However, the mechanisms by which the 2i condition limits ESC differentiation and whether RAS proteins are involved in this phenomenon...
Autores principales: | Mayor-Ruiz, Cristina, Olbrich, Teresa, Drosten, Matthias, Lecona, Emilio, Vega-Sendino, Maria, Ortega, Sagrario, Dominguez, Orlando, Barbacid, Mariano, Ruiz, Sergio, Fernandez-Capetillo, Oscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959239/ https://www.ncbi.nlm.nih.gov/pubmed/29650524 http://dx.doi.org/10.1101/gad.310086.117 |
Ejemplares similares
-
Ras in epidermal proliferation
por: Drosten, Matthias, et al.
Publicado: (2014) -
A Chemical Screen Identifies Compounds Capable of Selecting for Haploidy in Mammalian Cells
por: Olbrich, Teresa, et al.
Publicado: (2019) -
The ETS transcription factor ERF controls the exit from the naïve pluripotent state in a MAPK-dependent manner
por: Vega-Sendino, Maria, et al.
Publicado: (2021) -
Targeting KRAS mutant lung cancer: light at the end of the tunnel
por: Drosten, Matthias, et al.
Publicado: (2022) -
KRAS inhibitors: going noncovalent
por: Drosten, Matthias, et al.
Publicado: (2022)